Mammary-type myofibroblastomas: a report on four cases with emphasis on molecular profiling and literature review

Mammary-type myofibroblastomas: a report on four cases with emphasis on molecular profiling and literature review

Introduction. Myofibroblastomas of the breast are rare mesenchymal lesions thought to be derived from a CD34-positive mammary stromal cell that shows a great capacity for multipotency. Cases presentation. We performed a retrospective analysis of 4 cases with confirmed mammary myofibroblastomas. Hema...

Full description

Saved in:
Bibliographic Details
Published in:Archives of the Balkan Medical Union : the official journal of the Balkan Medical Union Vol. 55; no. 1; pp. 156 - 153
Main Authors: EVSEI, Anca, ANDREU, Javier F., BLAZQUEZ MAÑA, Carmen M., MENDEZ COCA, Inmaculada M., CARRERA SALA, Ruben, VAZQUEZ LUQUE, Jose A., RAMOS GUIJO, Carmen M., RODRIGUEZ MILLAN, Rosa M., GHEORGHE, Mircea, BIRCEANU-COROBEA, Adelina, COPCA, Narcis
Format: Journal Article
Language:English
Published: Balkan Medical Union 01-03-2020
Subjects:
breast
myofibroblastoma
next generation sequencing
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction. Myofibroblastomas of the breast are rare mesenchymal lesions thought to be derived from a CD34-positive mammary stromal cell that shows a great capacity for multipotency. Cases presentation. We performed a retrospective analysis of 4 cases with confirmed mammary myofibroblastomas. Hematoxylin and eosin slides and immunohistochemical slides were reviewed. For next-generation sequencing studies we used a TruSight Tumor 15 panel which ran in a MiSeq sequencer and was analyzed with illumina VariantStudio 3.0 and IGV (Integrative Genomic Variation). The case series consisted of 4 patients (3 men, 1 woman). The anatomic location distribution was equal, with a 1:1 ratio between the left and right breast and a gross median size of the lesion of 34 mm. Gross features revealed a well circumscribed lesion with a vaguely lobular cut surface and the microscopical features were that of a classic-type MFB composed of benign, spindle-shaped cells interrupted by thick collagen fibers that show extensive hyalinization. CD34 and desmin immunohistochemical markers were diffusely positive in tumor cells, thus confirming the diagnosis. Next generation sequencing used a TruSight Panel 15 and revealed mutations in TP53, p.P72R gene in two cases and in ERBB2 p.1655V, KIT c.2484C>T, GUSB p.V270M genes in one case. No pathogenic mutations were identified. Conclusions. The diagnosis of these tumors is challenging based on the rareness of these lesions. Molecular analyses are important to confirm the diagnosis based on morphology and immunohistochemistry. Given the fact that these tumors are rare and benign, there is little data about the molecular signature of this tumor.
ISSN:1584-9244
2558-815X
DOI:10.31688/ABMU.2020.55.1.18